Synchronous primary lung sarcomatous carcinoma and lung squamous cell carcinoma: a case report.

Maoyuan Zhao, Qiuyang Jing, Zhouguang Hui

Abstract read

In one paragraph

Article in International journal of clinical and experimental pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maoyuan ZhaoDepartment of Radiation Oncology, Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, 100021, China.

Qiuyang JingDepartment of Pathology, Sichuan University West China Second University Hospital, Sichuan University Sichuan 610000, China.

Zhouguang HuiDepartment of Radiation Oncology, Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, 100021, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcomatoid carcinoma (SC) is a rare primary malignant tumor, which seldom occurs in the lung, let alone as synchronous primary lung sarcomatous carcinoma and lung squamous cell carcinoma. We present a case of a 65-year-old Chinese man with a three-month history of cough and expectoration. The diagnosis was a combination of poorly differentiated synchronous central type primary lung sarcomatous carcinoma and lung squamous cell carcinoma with approximately 50% proportion of each, and the TNM classification was pT2aN1M0, at least AJCC Stage IIA. The purpose of the case report is to present the imaging, pathologic features, and treatment.

Indexed as

diagnosisLung sarcomatoid carcinomalung squamous cell carcinomatreatment

Identifiers

PMID32269685

PMCPMC7137031

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.